Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/18/2003US20030175705 Methods of use for novel single nucleotide polymorphisms of olfactory receptor-like polypeptides and nucleic acids encoding the same
09/18/2003US20030175702 Electronic array for solid phase synthesis; kits
09/18/2003US20030175699 Monitoring recognition activity of immunoglobulins using immobilized ligands; detecting sources of infection such as bacteria and viruses in urine
09/18/2003US20030175698 Retrovirus-specific oligonucleotides and a method for measuring retroviral titer using same
09/18/2003US20030175694 Method for determining biological agents in living target cells
09/18/2003US20030175692 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
09/18/2003US20030175691 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
09/18/2003US20030175690 Method to evaluate the hiv drug sensitivity
09/18/2003US20030175687 Classifiying, evaluating and characterizing microorganisms such as listeria, enterococcus and pseudomonas using flow cytometry and fluorescence; food processing; infection diagnosis
09/18/2003US20030175686 Diagnosing liver disorders using macroglobulin, hyaluronic acid (HA) and tissue inhibitor of metalloproteinases-1 (TIMP-1) concentrations; antifibrotic agents
09/18/2003US20030175685 Using amino acid sequences to control apoptosis and prevent or treat cancer and viral infections
09/18/2003US20030175683 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses
09/18/2003US20030175682 Screening for papilloma viruses
09/18/2003US20030175681 Inhibition of CMV infection and dissemination
09/18/2003US20030175680 Methods of treating and preventing bone loss
09/18/2003US20030175679 Detecting modulators of ubiquitin conjugating enzyme complex formation; drug screening
09/18/2003US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection
09/18/2003US20030175293 Choline binding proteins for anti-pneumococcal vaccines
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175285 Major histocompatibility complex ligands, comprising proteins, peptides, epitopes, polypeptides, mimetics or lipopeptides, used as vaccines
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175279 Diagnosing and prophylaxis of tumors, endometriosis and fibroids, by administering Endometrial Steroid Binding Protein II (ESBPII) antagonists, then analyzing the polypeptide concentration in cells, tissues or fluids
09/18/2003US20030175278 Ubiquilin, a presenilin interactor and methods of using same
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175273 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens
09/18/2003US20030175254 Separating population based on density and size of cells via elution then cetrifugation; for secretion of neuroendocrine hormones
09/18/2003US20030175253 Compositions and methods for diagnosing and treating mental disorders
09/18/2003US20030175250 Isolated peptides which bind to HLA molecules and uses thereof
09/18/2003US20030175210 Individualization of therapy with anxiolitics
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003US20030175208 Treating a cancer of the immune system
09/18/2003US20030175207 A chelated complex comprised of lantibiotics and a transition or lanthanide metal, for a chemiluminescent assay of bacteria or fungi; binding to grampositive or mycobacterial cells or gramnegative bacteria
09/18/2003US20030175169 Applicable for testing glucose in a body fluid such as blood or interstitial fluid
09/18/2003US20030175167 Apparatus for separating biological sample and separating method of the same
09/18/2003US20030175166 Sample cylinder, especially a sample cylinder that is provided with a filtration device for recovering cell material from body fluids
09/18/2003US20030175161 For electronic detection of chemical and biological materials
09/18/2003US20030175158 Test strip qualification system
09/18/2003US20030175156 Comprises prepackaged cartridge for dispension of clear polyvinyl chloride cylinders; materials handling
09/18/2003US20030175155 Blood glucose monitoring systems; comprises plate adapted to press the sliding conveying member against open top forming moisture-impervious seal
09/18/2003US20030175153 Comprises glass fiber matrices; high density lipoproteins (HDL)
09/18/2003US20030174923 Detecting and/or measuring a substance based on a resonance shift of photons orbiting within a microsphere
09/18/2003US20030174563 Solid phase sensors
09/18/2003US20030173980 Concentration detector
09/18/2003US20030173970 Device and method for detecting oil deterioration
09/18/2003US20030173959 Electromagnetic analysis of concrete tensioning wires
09/18/2003US20030173513 Probe for mass spectrometry
09/18/2003US20030173233 For detecting and measuring gases dissolved in liquids, particularly gases dissolved in liquids which return to their gaseous state under certain conditions of temperature and pH
09/18/2003US20030172741 Sampling system for exhaust gas sensors and method of using same
09/18/2003US20030172725 System and method for determining fouling tendency by refinery feed stocks
09/18/2003US20030172722 Method of evaluating the wear of engine oil taking into account the addition of fresh oil
09/18/2003US20030172717 Odor measuring apparatus
09/18/2003US20030172716 Method and device for the monitoring of gases
09/18/2003US20030172715 Simple dissolved carbon dioxide analyzer
09/18/2003DE20310023U1 Monitoring station for measurement of individual gas concentrations in gas or gas-liquid mixtures protects a sensitive sensor against high concentration damage by inert or diluent gas purging
09/18/2003CA2813780A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2737892A1 Apparatus and methods for analyte measurement and immunoassay
09/18/2003CA2671976A1 Methods of inducing terminal differentiation
09/18/2003CA2481312A1 Tagging and recovery of elements associated with target molecules
09/18/2003CA2478963A1 Method of generating molecule-function network
09/18/2003CA2478924A1 Cancer associated araf1 protein kinase and its uses
09/18/2003CA2478823A1 Method for the evaluation of velvet antler
09/18/2003CA2478683A1 Antibodies against cancer antigen tmeff2 and uses thereof
09/18/2003CA2478640A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors
09/18/2003CA2478607A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478605A1 Methods for identifying large subsets of differentially expressed genes based on multivariate microarray data analysis
09/18/2003CA2478593A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478592A1 Genomic screen for epigenetically silenced genes associated with cancer
09/18/2003CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003CA2478529A1 In vitro serological method of diagnosing infective endocarditis
09/18/2003CA2478510A1 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003CA2478413A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
09/18/2003CA2478239A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
09/18/2003CA2478173A1 Novel method of highly sensitive nucleic acid analysis
09/18/2003CA2478116A1 Neoplasm specific antibodies and uses thereof
09/18/2003CA2478110A1 Novel fluorescent label compounds
09/18/2003CA2478102A1 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003CA2478083A1 Biospecific contrast agents
09/18/2003CA2478036A1 Use of biomarkers to detect breast cancer
09/18/2003CA2478032A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/18/2003CA2478029A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003CA2477980A1 Crystalline structure of human mapkap kinase-2
09/18/2003CA2477614A1 Biomarker for efficacy of appetite suppressant drugs
09/18/2003CA2476767A1 Use of the mal protein as a tumour marker
09/18/2003CA2476044A1 Current-to-voltage converter
09/18/2003CA2475516A1 Multiplex analysis using membrane-bound sensitizers
09/18/2003CA2472119A1 Screening method for orthopoxvirus antivirals
09/18/2003CA2457473A1 Device and methods for measuring the response of at least one cell to a medium
09/18/2003CA2422326A1 Swab testing device and method
09/18/2003CA2419905A1 Storage cartridge for biosensors
09/17/2003EP1345137A1 Method and system for providing gene analysis information and authentication identification method
09/17/2003EP1345030A1 Test strip qualification system
09/17/2003EP1345029A1 Test strip qualification system
09/17/2003EP1345027A1 Apparatus for measuring wood humidity in lumber piles
09/17/2003EP1345026A2 System, method, and product for scanning of biological materials
09/17/2003EP1344836A2 Random array of micro-spheres for the analysis of nucleic acid using enzyme digestion
09/17/2003EP1344835A2 Real-time nucleic acid detection processes and compositions
09/17/2003EP1344831A1 Method of measuring cell death of target cells
09/17/2003EP1344819A2 Human hematopoietic stem cell
09/17/2003EP1344567A1 Centrifugal separator and analyzer with the separator